Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DiaMedica Therapeutics Inc. - Common Stock
(NQ:
DMAC
)
7.575
-0.965 (-11.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DiaMedica Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Insights Ahead: DiaMedica Therapeutics's Quarterly Earnings
↗
May 12, 2025
Via
Benzinga
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
May 08, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
May 07, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
April 15, 2025
Via
Benzinga
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
Preview: DiaMedica Therapeutics's Earnings
↗
November 12, 2024
Via
Benzinga
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
March 17, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For March 17, 2025
↗
March 17, 2025
Via
Benzinga
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
March 11, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors
February 24, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
February 20, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 10, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia
December 03, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
November 13, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia
November 13, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference
November 12, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
November 06, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
October 09, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 07, 2024
Via
Benzinga
DiaMedica Therapeutics Upcoming Conference Participation
September 04, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024
↗
August 07, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
August 07, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024
August 01, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Releases Preeclampsia White Paper and Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
July 11, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement
July 01, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces $11.8 Million Private Placement
June 26, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
June 26, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024
↗
May 08, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
May 08, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
May 02, 2024
From
DiaMedica Therapeutics Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
